Matthew Might, PhD

Dr. Matt Might has been the director of the Hugh Kaul Precision Medicine Institute at the University of Alabama at Birmingham (UAB) since 2017. At UAB, Matt is a professor of internal medicine and computer science. From 2016 to 2018, Matt was a strategist in the Executive Office of the President in The White House for the Precision Medicine Initiative. In 2015, Matt joined the faculty of the Department of Biomedical Informatics at the Harvard Medical School, first as visiting professor and since 2017 as senior lecturer. Previously, Matt was a professor in computer science at the University of Utah.

Matt's research focuses on finding treatments for the rarest diseases in the world because hope is a right that belongs to all patients.

Matt's journey from computer science to medicine has been inspired by his son Bertrand. In 2012, Bertrand was the first patient in the world to be diagnosed with NGLY1 deficiency, and this inspired Matt to use social media to discover other patients and form a community. Through the community's efforts in science, two therapeutics for NGLY1 deficiency have now been identified, and Matt leads several efforts to develop more.

Matt tweets from @mattmight and blogs from blog.might.net.